학술논문
Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
Document Type
Article
Author
Kennedy, O.J.; Lorigan, P.; Kicinski, M.; Suciu, S.; Valpione, S.; Gandini, S.; Blank, C.U.; Long, G.V.; Atkinson, V.G.; Dalle, S.; Haydon, A.M.; Meshcheryakov, A.; Khattak, A.; Carlino, M.S.; Sandhu, S.; Larkin, J.; Puig, S.; Ascierto, P.A.; Rutkowski, P.; Schadendorf, D.; Boers-Sonderen, M.; Di Giacomo, A.M.; van den Eertwegh, A.J.M.; Grob, J.-J.; Gutzmer, R.; Jamal, R.; van Akkooi, A.C.J.; Robert, C.; Eggermont, A.M.M.; Mandala, M.
Source
In: European Journal of Cancer . (European Journal of Cancer, August 2023, 189)
Subject
Language
English
ISSN
18790852
09598049
09598049